ATRANORINNING SITOTOKSIK FAOLLIGINI O’RGANISH
Abstract
Ish biomoslashuv, sito- va genotoksiklik ta'sir mexanizmi va istiqbollarini o'rganishga bag'ishlangan.
References
Lichen Biology 104–133, Cambridge University Press, 2008, https://doi.org/
1017/CBO9780511790478.008.
Hawksworth, D. L. Supplement to “Chemical and Botanical Guide to Lichen
Products”. By Chicita F. Culberson. The American Bryological and Lichenological Society (Reprinted from Bryologist, 73: (177–377). 1970. The Lichenologist 5, 179–179 (1971).
M.J. Calcott, D.F. Ackerley, A. Knight, R.A. Keyzers, J.G. Owen, Secondary
metabolism in the lichen symbiosis, Chem. Soc. Rev. 47 (2018) 1730–1760.
S. Shibata, Yasuhiko Asahina (1880–1975) and His Studies on lichenology and
chemistry of lichen metabolites on JSTOR, Bryologist 103 (2000) 710–719.
E. Studzinska-Sroka, A. Galanty, W. Bylka, Atranorin - an interesting lichen
secondary metabolite, Mini-Rev. Med. Chem. 17 (2017).
M. Kosanić, B. Ranković, T. Stanojković, A. Rančić, N. Manojlović, Cladonia
lichens and their major metabolites as possible natural antioxidant, antimicrobial
and anticancer agents, LWT - Food Sci. Technol. 59 (2014) 518–525.
B. Ranković, M. Mišić, S. Sukdolak, The antimicrobial activity of substances
derived from the lichens Physcia aipolia, Umbilicaria polyphylla, Parmelia
caperata and Hypogymnia physodes, World J. Microbiol. Biotechnol. 24 (2008)
Semenov, K. N., Prokopiev, I. A., Petukhova, N. V., Kremenetskaya, U. A., Senichkina, D. A., Epifanovskaya, O. S., ... & Sharoyko, V. V. (2024).
Atranorin is a novel potential candidate drug for treating myelodysplastic syndrome. Journal of Molecular Liquids, 413, 125743.
Semenov K. N. et al. Development of Graphene-Based Materials with the Targeted Action for Cancer Theranostics //Biochemistry (Moscow). – 2024. – Т. 89. – №. 8. – С. 1362-1391.
